Gencurix Droplex POLE Study Published in Journal, Spotlight on Endometrial Cancer Testing

Gencurix, a precision medicine diagnostics company, said a study on its digital PCR (ddPCR)-based Droplex POLE Mutation Test for detecting POLE mutations in endometrial cancer has been published in an international academic journal. The study addresses testing technology aimed at POLE mutation detection in the endometrial cancer diagnostic field. The key point is that Droplex POLE Mutation Test is based on the ddPCR method. The company said the publication marks academic disclosure of the related testing technology. Interest in POLE mutation detection technology may continue in the field of precision diagnostics for endometrial cancer. Source: mk.co.kr